Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time in Therapeutic Range, Predictors of Poor Anticoagulation Control, and Clinical Outcomes in Egyptian Patients With Rheumatic Heart Disease and Atrial Fibrillation on Warfarin: A Single Center Retrospective-Prospective Cohort Study

NCT07826299 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07826299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time in Therapeutic Range, Predictors of Poor Anticoagulation Control, and Clinical Outcomes in Egyptian Patients With Rheumatic Heart Disease and Atrial Fibrillation on Warfarin: A Single Center Retrospective-Prospective Cohort Study
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

af